Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (785)

Concordance with national comprehensive cancer network (NCCN) clinical practice guidelines (CPGs): A quality of care tool for newly diagnosed patients (pts) with mantle cell lymphoma (MCL)

Meeting Abstract

Rodriguez, M. A.; ter Veer, A.; Nademanee, A.; Niland, J.; Lepisto, E.; Kho, M.; LaCasce, A.; Weeks, J. C.; Czuczman, M.; Millenson, M.; more...
Blood (2006)

Fulltext@MSK | Save

Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience

Meeting Abstract

O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Early phase experience with pralatrexate (10-propargyl-10-deazaaminopterin [PRX]), a novel antifolate with high affinity for the reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies

Meeting Abstract

O'connor, O.; Hamlin, P.; Neylon, E.; Moskowitz, C.; Portlock, C.; Noy, A.; Sirotnak, F.; Zelenetz, A.; Mould, D.; Horwitz, S.
EJC Supplements (2006)

Fulltext@MSK | Save

Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL

Meeting Abstract

Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
Blood (2006)

Fulltext@MSK | Save

FDG-PET scans as a staging study for T-cell lymphomas: High rates of positivity do not result in frequent changes in stage

Meeting Abstract

Horwitz, S. M.; Foss, F.; Goldfarb, S.; Molina, A.; Hamlin, P. A.; O'Connor, O. A.; Cammarata, M.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2006)

Fulltext@MSK | Save

Relapsed and refractory primary mediastinal diffuse large B-cell lymphoma: Outcome with ICE-based treatment

Meeting Abstract

Hamlin, P. A.; Dickson, M.; Kewalramani, T.; Horwitz, S. M.; Portlock, C. S.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2006)

Fulltext@MSK | Save

The schedule dependent combination of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) produces minimal toxicity, even at relatively high doses of proteasome inhibitor, in patients with relapsed/refractory indolent B-cell lymphomproliferative disorders

Meeting Abstract

Gerecitano, J.; Portlock, C.; Noy, A.; Hamlin, P.; Moskowitz, C.; Straus, D.; Horwitz, S. M.; Palomba, M. L.; Dumitrescu, O. L.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Initial therapeutic strategy in follicular lymphoma (FL): An analysis from the National LymphoCare Study (NLCS)

Meeting Abstract

Friedberg, J. W.; Huang, J.; Dillon, H.; Farber, C.; Feliciano, S.; Hainsworth, J.; Link, B.; Steis, R.; Vose, J.; Zelenetz, A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Non-Hodgkin's lymphoma: Clinical practice guidelines in oncology™

Journal Article

Zelenetz, A. D.; Advani, R. H.; Buadi, F.; Cabanillas, F.; Caligiuri, M. A.; Czuczman, M. S.; Damon, L. E.; Fayad, L.; Flinn, I. W.; Forero, A.; more...
Journal of the National Comprehensive Cancer Network (2006)

Fulltext@MSK | Save

Mantle cell lymphoma: An update on management

Journal Article

Zelenetz, A. D.
Annals of Oncology (2006)

Fulltext@MSK | Save